We came across a bullish thesis on Hims & Hers Health, Inc. on PatchTogether Investing’s Substack. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.'s share was trading at $48.11 as of September 4th. HIMS’s trailing and forward P/E were 60.90 and 62.50 respectively according to Yahoo Finance.
Hims & Hers (NYSE: HIMS) saw its stock fall 30% after Q2 2025 earnings as investors questioned whether its growth story is losing steam. Revenue fell sequentially for the first time, from $586M in Q1 to $545M in Q2, driven by weakness in weight loss and...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.